Antithrombotic therapy trends in non-valvular atrial fibrillation patients undergoing percutaneous coronary stent implantation: Results from a survey among fellows at the Japanese College of Cardiology

The questionnaire showed variation in antithrombotic therapy used for OAC-treated AF patients after stenting, and how it changes year by year. Although the duration of DAPT tended to shorten, variations are still observed, i.e. the selection of a single antiplatelet or OAC.